Clinical Trials and Studies

1. Does Re-hydration Necessarily Imply Re-Oxygenation in Sickling Reversal: The Gardos Phenomenon-revisited. A Case for Cellod-S Herbal Remedy.

Coker H. A. B, Kehinde M. O, Temiye E. O, Banjo A. A. F, Elesha S. O, Sofola O. A, Ajala O. S, Alaribe S. C, Adesogun S. A, Owolabi M. O, Sodipo J. O. A and Renner J. K.

Natural Medicine and Molecular Pharmaco-Biotechnology Labouratories-Faculty of Pharmacy, College of Medicine, University of Lagos.

Conclusion: “The results of the pre-clinical evaluations indicate that Cellod-S has the acclaimed antisickling ethnomedicinal use and that haemolysis– a major mechanism-based toxicity of potential antisickling agents, and phenomenon most guided against in sickle cell sufferers-is not a problem with Cellod-S. We therefore recommend Cellod-S for extensive clinical evaluations in humans”

2. The efficacy of Procin-X and Cellod-S in the management of Benign Prostatic Enlargement 

K.H. Tijani, M. K. Adegoke, E. A. Jeje, K. I. Okolie, R. W. Ojewola, M. A. Ogunjimi.

Departments of Surgery, Section of Urology and Chemical Pathology, Lagos University Teaching Hospital, Surulere, Lagos, Nigeria.

Conclusion: “Procin-X + Cellod-S therapy (PC) appears to be effective and in the management of Lower Urinary Tract Symptoms (LUTS) caused by Benign Prostate Hyperplasia (BPH). This efficacy appears to match that of a combination therapy of a 5ARI and A1B. The key advantages of PC include the absence of known side effects, the apparent improvement of erectile function with a simultaneous reduction in PSA, and no significant effect on serum testosterone. It may thus also find additional role in the chemoprevention of prostate cancer. A large multicenter double blind study is however needed to confirm these findings”

 

See Publications for full reports